These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8098296)

  • 1. Cytidine deaminase activity in abnormal pregnancy.
    Okamura T; Kigasawa K; Takeuchi T; Ohta C
    Int J Gynaecol Obstet; 1993 Apr; 41(1):53-60. PubMed ID: 8098296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of the colorimetric assay for cytidine deaminase activity.
    Okamura T; Kigasawa K
    Prenat Diagn; 1994 Mar; 14(3):213-8. PubMed ID: 8052571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytidine deaminase assay--some pitfalls.
    Jones DD; Roberts EL; Williams GF
    Br J Obstet Gynaecol; 1986 Apr; 93(4):407-8. PubMed ID: 3964620
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of serum cytidine deaminase during pregnancy.
    Jones DD; Bahijri S; Roberts EL; Williams GF
    Br J Obstet Gynaecol; 1982 Apr; 89(4):314-7. PubMed ID: 7073999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subcellular distribution of adenosine-, adenosine-5-monophosphate- and cytidine-5-monophosphate desaminase activity in the humna placenta and amnion tissue].
    Zoch E; Häge R
    Zentralbl Gynakol; 1977; 99(6):337-42. PubMed ID: 868358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytidine deaminase: a rapid method of purification and some properties of the enzyme from human placenta.
    Vita A; Vincenzetti S; Amici A; Ferretti E; Magni G
    Adv Exp Med Biol; 1991; 309B():235-8. PubMed ID: 1781374
    [No Abstract]   [Full Text] [Related]  

  • 7. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placenta cytidine deaminase: proton-linked enzyme activity and substrate binding.
    Vincenzetti S; Angeletti M; Lupidi G; Cambi A; Natalini P; Vita A
    Biochem Mol Biol Int; 1997 Jul; 42(3):477-86. PubMed ID: 9247705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
    Williams GF; Jones DD
    Br J Obstet Gynaecol; 1982 Apr; 89(4):309-13. PubMed ID: 7073998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic oxaloacetic and glutamic pyruvate transaminases in the placenta, maternal and cord sera of undernourished mothers and non-pregnant women.
    Bhatia BD; Katiyar GP; Agarwal KN
    Indian J Med Res; 1977 Nov; 66(5):794-801. PubMed ID: 608748
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytidine deaminase--a marker for pre-eclampsia?
    Baines TJ; Clark A
    Ann Clin Biochem; 1985 Jul; 22 ( Pt 4)():420-2. PubMed ID: 4037669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental thyroxine inner ring monodeiodinase in complicated pregnancy.
    Yoshida K; Suzuki M; Sakurada T; Shinkawa O; Takahashi T; Furuhashi N; Kaise N; Kaise K; Kitaoka H; Fukazawa H
    Metabolism; 1985 Jun; 34(6):535-8. PubMed ID: 3999974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of plasma cytidine deaminase activity by HPLC.
    Richards DA; Sherwood RA; Ndebele D; Rocks BF
    Biomed Chromatogr; 1987; 2(4):148-51. PubMed ID: 3507226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord serum creatine kinase BB in the diagnosis of brain damage in the newborn: problems in interpretation.
    Kumpel B; Wood SM; Anthony PP; Brimblecombe FS
    Arch Dis Child; 1983 May; 58(5):382-3. PubMed ID: 6859922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia index in the prediction of abnormal CTG at delivery in uncomplicated pregnancies.
    Ropacka-Lesiak M; Korbelak T; Breborowicz G
    Neuro Endocrinol Lett; 2013; 34(1):75-80. PubMed ID: 23524628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and cord serum vitamin E levels in normal and abnormal pregnancy.
    von Mandach U; Huch R; Huch A
    Int J Vitam Nutr Res; 1994; 64(1):26-32. PubMed ID: 8200744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of some serum, urinary and placental aminopeptidase activities].
    de Kerleau JC; Cristol P; Chapon JP
    Rev Fr Gynecol Obstet; 1967 Sep; 62(9):449-50. PubMed ID: 5618600
    [No Abstract]   [Full Text] [Related]  

  • 19. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal fibronectin as a marker to discriminate between ectopic and intrauterine pregnancies.
    Ness RB; McLaughlin MT; Heine RP; Bass DC; Mortimer L
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):697-702. PubMed ID: 9757974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.